Pathophysiological roles of endothelin-1 in Dahl salt-sensitive hypertension

Hypertension

Volumn 34, Issue 3, 1999, Pages 514-519

  Ikeda, Takanori ^a   Ohta, Hisashi ^a   Okada, Megumu ^a   Kawai, Nobuko ^a   Nakao, Rumi ^a   Siegl, Peter K S ^c   Kobayashi, Tsutomu ^a   Maeda, Seiji ^b   Miyauchi, Takashi ^b   Nishikibe, Masaru ^a,d  

^a BANYU PHARMACEUTICAL CO LTD   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c MERCK RESEARCH LABORATORIES   (United States)

^d Tsukuba Research Institute   (Japan)

Author keywords

Endothelin; Hypertension; Kidney; Rats, Dahl; Receptors, endothelin

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR ANTAGONIST; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; HYPERTENSION; KIDNEY; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALT INTAKE;

EID: 0032886768     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.34.3.514     Document Type: Article

References (27)

1. Yanagisawa M, Kurihara M, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332:411-415.
2. Highsmith RF, ed. Endothelin Molecular Biology, Physiology, and Pathology. Totowa, NJ: Human Press; 1998.
3. Ferri C, Bellini C, Desideri G, Mazzocchi C, De Siati L, Santucci A. Elevated plasma and urinary endothelin-1 levels in human salt-sensitive hypertension. Clin Sci. 1997;93:35-41.
4. Mortensen LH, Fink GD. Salt-dependency of endothelin-induced, chronic hypertension in conscious rats. Hypertension. 1992;19:549-554.
5. Dahl LK, Heine M, Tassinari L. Effects of chronic salt ingestion: evidence that genetic factors play an important role in susceptibility to experimental hypertension. J Exp Med. 1962;115:1173-1190.
6. Dahl LK, Heine M. Primary role of renal homografts in setting chronic blood pressure levels in rats. Circ Res. 1975;36:692-696.
7. Deng LY, Day R, Schiffrin EL. Localization of sites of enhanced expression of endothelin-1 in the kidney of DOCA-salt hypertensive rats. J Am Soc Nephrol. 1996;7:1158-1164.
8. Madeddu P, Troffa C, Glorioso N, Pazzola A, Soro A, Manunta P, Tonolo G, Demontis MP, Varoni MV, Anania V. Effect of endothelin on regional hemodynamics and renal function in awake normotensive rats. J Cardiovasc Pharmacol. 1989;14:818-825.
9. Badr KF, Murray JJ, Breyer MD, Takahashi K, Inagami T, Harris RC. Mesangial cell, glomerular and renal vascular responses to endothelin in the rat kidney. J Clin Invest. 1989;83:336-342.
10. Goets KL, Wang BC, Madwed JB, Zhu JL, Leadley RJ Jr. Cardiovascular, renal, and endocrine responses to intravenous endothelin in conscious dogs. Am J Physiol. 1988;255:R1064-R1068.
11. Clavell AL, Stingo AJ, Margulies KB, Brandt RR, Burnett JC Jr. Role of endothelin receptor subtypes in the in vivo regulation of renal function. Am J Physiol. 1995;268:F455-F460.
12. A receptor blockade prevents increased tissue endothelin-1, vascular hypertrophy, and endothelial dysfunction in salt-sensitive hypertension. Hypertension. 1998;31(pt 2):499-504.
13. Doucet J, Gonzalez W, Michel JB. Endothelin antagonists in salt-dependent hypertension associated with renal insufficiency. J Cardiovasc Pharmacol. 1996;27:643-651.
14. B endothelin receptor antagonist. J Pharmacol Exp Ther. 1999;289:1262-1270.
15. Maeda S, Miyauchi T, Sakai S, Kobayashi T, Iemitsu M, Goto K, Sugishita Y, Matsuda M. Prolonged exercise causes an increase in endothelin-1 production in the heart in rats. Am J Physiol. 1998;268: F455-F460.
16. Sakurai T, Yanagisawa M, Inoue A, Ruan US, Kimura S, Mitsui Y, Goto K, Masaki T. cDNA cloning, sequence analysis and tissue distribution of rat preproendothelin-1 mRNA. Biochem Biophys Res Commun. 1991;77: 165-172.
17. Tso JY, Sun XH, Kao TH, Reece KS, Wu R. Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNA: genomic complexity and molecular evolution of the gene. Nucleic Acids Res. 1985;13:2485-2502.
18. Sakai S, Miyauchi T, Kobayashi M, Yamaguchi I, Goto K, Sugishita Y. Inhibition of myocardial endothelin pathway improves long-term survival in heart failure. Nature. 1996;384:353-355.
19. Roman RJ. Abnormal renal hemodynamics and pressure-natriuresis relationship in Dahl salt-sensitive rats. Am J Physiol. 1986;251:F57-F65.
20. Feron O, Salomone S, Godfraind T. Influence of salt loading on the cardiac and renal preproendothelin-1 mRNA expression in stroke-prone spontaneously hypertensive rats. Biochem Biophys Res Commun. 1995; 209:161-166.
21. Kassab S, Novak J, Miller T, Kirchner K, Granger J. Role of endothelin in mediating the attenuated renal hemodynamics in Dahl salt-sensitive hypertension. Hypertension. 1997;30(pt 2):682-686.
22. Kassab S, Miller T, Novak J, Reckelhoff J, Clower B, Granger JP. Endothelin-A receptor antagonism attenuates the hypertension and renal injury in Dahl salt-sensitive rats. Hypertension. 1998;31(pt 2):397-402.
23. Goligorsky MS, Iijima K, Morgan M, Yanagisawa M, Masaki T, Lin L, Nasjletti A, Kaskel F, Frazer M. Role of endothelin in the development of Dahl hypertension. J Cardiovasc Pharmacol. 1991;17(suppl 7):S484-S491.
24. Kong J-Q, Taylor D, Fleming WW. Sustained hypertension in Dahl rats: negative correlation of agonist response to blood pressure. Hypertension. 1995;25:139-145.
25. A receptor in the maintenance of deoxycorticosterone acetate-salt-induced hypertension. Br J Pharmacol. 1995;114:925-930.
26. A receptor-mediated role of endothelin in the kidney of DOCA-salt hypertensive rats. Life Sci. 1996;58:PL1-PL7.
27. Larivière R, Thibault G, Schiffrin EL. Increased endothelin-1 content in blood vessels of deoxycorticosterone acetate-salt hypertensive but not in spontaneously hypertensive rats. Hypertension. 1993;21:294-300.